Divi’s Laboratories shares gain another 5% after Q2 results. Here’s why Jefferies raised target price by 23%
Shares of Divi’s Laboratories jumped 5% following a 64% YoY surge in Q2 FY27 net profit to Rs 1,127 crore. Brokerage Jefferies raised its target price by 23% to Rs 12,550, citing robust CDMO business expansion, strong EBITDA margins, and a solid GLP peptide pipeline.
Full story
Read the full story at The Economic Times (India) ↗
Continue reading this story on The Economic Times (India), the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.
